Cargando…
Fluconazole resistant Candida auris clinical isolates have increased levels of cell wall chitin and increased susceptibility to a glucosamine-6-phosphate synthase inhibitor
In 2009 Candida auris was first isolated as fungal pathogen of human disease from ear canal of a patient in Japan. In less than a decade, this pathogen has rapidly spread around the world and has now become a major health challenge that is of particular concern because many strains are resistant to...
Autores principales: | Shahi, Garima, Kumar, Mohit, Skwarecki, Andrzej S., Edmondson, Matt, Banerjee, Atanu, Usher, Jane, Gow, Neil A.R., Milewski, Sławomir, Prasad, Rajendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891998/ https://www.ncbi.nlm.nih.gov/pubmed/35252632 http://dx.doi.org/10.1016/j.tcsw.2022.100076 |
Ejemplares similares
-
Inhibitors of glucosamine-6-phosphate synthase as potential antimicrobials or antidiabetics – synthesis and properties
por: Stefaniak, Joanna, et al.
Publicado: (2022) -
Gene Duplication Associated with Increased Fluconazole Tolerance in Candida auris cells of Advanced Generational Age
por: Bhattacharya, Somanon, et al.
Publicado: (2019) -
Cell wall protection by the Candida albicans class I chitin synthases
por: Preechasuth, Kanya, et al.
Publicado: (2015) -
Long range molecular dynamics study of regulation of eukaryotic glucosamine-6-phosphate synthase activity by UDP-GlcNAc
por: Miszkiel, Aleksandra, et al.
Publicado: (2011) -
Dissection of the Candida albicans class I chitin synthase promoters
por: Lenardon, Megan D., et al.
Publicado: (2009)